2330 closes the week at TWD 2,395 — up 3.2% — partly reclaiming the territory lost in the post-earnings slide and putting the one-month decline to roughly 0.8%, a sharp improvement from the -5.1% that defined last week's note.
The peer picture this week is notably mixed, which makes TSMC's recovery more interesting than it first appears. Closest correlated peer 6857 surged 10.5% on the week, and 3711 added 7.5% — both outpacing TSMC's gain. At the other end, 6323 fell 5.9% and 6590 dropped 8.7%, confirming this is not a uniform sector re-rating. TSMC's middle-of-the-pack finish suggests its recovery is grounded in company-specific fundamentals — the 44.7% year-on-year July revenue print and the Microsoft Maia capacity discussions reported earlier in the week — rather than sector momentum alone.
The lending market continues to carry no useful directional signal. Borrow availability remains at its effective ceiling, with the lending pool so deep relative to short demand that the metric reads at maximum capacity — a position it has held without interruption throughout the past 30 days. Cost to borrow has eased about 10% on the week to 0.71%, though it is running roughly double the level it sat at in mid-July, when it was below 0.36%. That month-on-month doubling in borrow cost is worth noting, but at an absolute level of under 1%, it remains unambiguously cheap. Short interest itself is structurally negligible — the short score of 25.2 ranks in the 96th percentile for low short pressure. The borrowing market is, in short, unanimous: there is no meaningful bearish conviction expressed through the lending channel.
The Street angle is complicated by the age of available analyst data — formal price targets on file are more than four years old and cannot be cited as current guidance. What the factor scores do offer is a coherent quality picture: EPS momentum ranks in the 71st percentile on a 30-day basis and 64th on 90-day, while EPS surprise also sits at the 64th percentile. The EV/EBIT factor ranks in the 76th percentile. The one lagging dimension is forward earnings growth, where the 12-month forward year-on-year EPS increase ranks only in the 24th percentile — a reminder that even with 44.7% revenue growth, the base effects from 2025's strong cycle are narrowing the forward comparison. The trailing PE has compressed about 10% over 30 days to roughly 19x, while EV/EBITDA has moved in the same direction, down nearly a full turn to 12.6x. Valuation is becoming less demanding as earnings outperform the price.
Insider activity adds a mild supporting note. Two vice presidents — Tien, Bor-Zen and Lin, Shyue-Shyh — have been buying consistently across July and into early August, accumulating shares across more than ten separate transactions. Individual ticket sizes are small, in the $70,000-$75,000 range, and significance scores are low at 3 out of 10. The 90-day net buy figure across all insiders is approximately $15.2M, which for a company of this scale is modest. The pattern is notable for its consistency rather than its size — two officers buying in multiple tranches through a period when the stock was under pressure.
The next earnings event is scheduled for October 16. The most recent print — July 16 — produced a 6.1% one-day decline followed by a partial five-day recovery of roughly 1.4%, suggesting the market's habit of selling the initial reaction and then reassessing. Between now and October, the monthly revenue releases will be the primary data cadence to track, with the August figure the next concrete test of whether the 44.7% year-on-year pace from July can hold.
See the live data behind this article on ORTEX.
Open 2330 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
